Cocrystal Pharma to Present at the H.C. Wainwright Global Life Sciences Virtual Conference [UPDATED]

Rhea-AI Summary

Cocrystal Pharma (Nasdaq: COCP) will present an overview and hold virtual investor meetings at the H.C. Wainwright Global Life Sciences Virtual Conference on March 9-10, 2021. The conference will showcase the company's efforts in discovering and developing innovative antiviral therapeutics for various viruses, including influenza and SARS-CoV-2. Access to the webcast presentation is available through registration for the conference, starting from March 9 at 7:00 a.m. Eastern time to March 10 at 9:00 p.m. Eastern time.

BOTHELL, Wash., March 02, 2021 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP), (“Cocrystal” or the “Company”), a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, the SARS-CoV-2 virus, hepatitis C viruses and noroviruses, announces that management will present a company overview and hold virtual investor meetings at the H.C. Wainwright Global Life Sciences Virtual Conference being held March 9-10, 2021.

The Cocrystal Pharma webcast presentation can be accessed by registering for the H.C. Wainwright Global Life Sciences Virtual Conference here. The webcast will be available on the H.C. Wainwright Conference Portal beginning March 9, 2021 at 7:00 a.m. Eastern time through March 10, 2021 at 9:00 p.m. Eastern time. The Company’s corporate presentation can be accessed from the Investor Relations section of the Company website here.

About Cocrystal Pharma, Inc.
Cocrystal Pharma, Inc. is a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication process of influenza viruses, coronaviruses (including SARS-CoV-2), hepatitis C viruses and noroviruses. Cocrystal employs unique structure-based technologies and Nobel Prize-winning expertise to create first- and best-in-class antiviral drugs. For further information about Cocrystal, please visit www.cocrystalpharma.com.

Investor Contact:
LHA Investor Relations
Jody Cain
310-691-7100
jcain@lhai.com

FAQ

What will Cocrystal Pharma present at the H.C. Wainwright conference?

Cocrystal Pharma will present a company overview and hold virtual investor meetings.

When is the H.C. Wainwright Global Life Sciences Virtual Conference?

The conference is scheduled for March 9-10, 2021.

How can I access Cocrystal's webcast presentation?

The webcast presentation can be accessed by registering for the conference, available from March 9 at 7:00 a.m. to March 10 at 9:00 p.m. Eastern time.

What type of therapeutics does Cocrystal Pharma develop?

Cocrystal Pharma focuses on antiviral therapeutics targeting influenza viruses, SARS-CoV-2, hepatitis C, and noroviruses.

What is the ticker symbol for Cocrystal Pharma?

The ticker symbol for Cocrystal Pharma is COCP.